Kidney Research UK invests £2.9 Million into research.
Dr John Bradley & his team in Cambridge discover that a protein called TNF may one day make it possible to instruct cells in a kidney tumour to die. This would reduce the growth of the cancerous tumour.
800 new cases of chronic kidney disease (CKD) diagnosed through a project conducted by Kidney Research UK involving 20 GP Practices. The project was conducted in order to implement a package of patient care techniques for the treatment of CKD.
A world first breakthrough in kidney transplantation and first trials in man, funded by Kidney Research UK. Professor Mike Nicholson and his team at Leicester pioneered the warm perfusion technique which pumps oxygenated blood through donated kidneys prior to transplantation. Could reduce the transplant waiting list by 10-20%.
Kidney Research UK's Making Every Kidney Count campaign is launched.
Dialysis Decision Aid, funded by Kidney Research UK is introduced, helping healthcare professionals and patients in decision making and choosing the best treatment to meet lifestyle requirements.
The National Institute for Health and Care Excellence (NICE) recommends Eculizumab for treating a very rare life-threatening type of kidney disease called aHUS following Kidney Research UK funded research.
Kidney Research UK's Missing Million awareness campaign is launched.
Kidney Research UK Invests £5.1 Million into research.
The European Medicines Agency (EMA) recommended Tolvaptan for approval. First ever pharmaceutical treatment available in Europe for ADPKD patients.
BBC Lifeline Appeal is launched in July. The most high profile fundraising campaign for Kidney Research UK yet.
Professor Lombardi is taking forward her research into the T-Regs potential from 1992 in a clinical trial as part of an international consortium.